PDCD1 and neoplasm: Since PD-1 treatment alone does not affect tumor growth21, we reasoned that any genes among the 16 that are higher in the PD-1-treated tumors compared to IgG controls, but unchanged or lower in responder tumors harboring shDDR2 and PD-1 treated, could conceivably be ideal additional targets for therapy.